Schedule 13D ownership disclosure

CUREVAC N V

Common Shares, par value (euro)0.12 per share · CUSIP: N2451R105

Event date: 2025-06-12

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • dievini Hopp BioTech holding GmbH & Co. KGReported CIK 0001696029

    Shares: 70,181,760.00 · Class: 31.3%

  • DH-LT-Investments GmbH

    Shares: 8,753,595.00 · Class: 3.9%

  • DH-Capital GmbH & Co. KG

    Shares: 70,181,760.00 · Class: 31.3%

  • OH Beteiligungen GmbH & Co. KG

    Shares: 70,181,760.00 · Class: 31.3%

  • Dietmar Hopp

    Shares: 82,373,544.00 · Class: 36.7%

  • Oliver Hopp

    Shares: 70,181,760.00 · Class: 31.3%

  • Daniel Hopp

    Shares: 70,181,760.00 · Class: 31.3%

  • DHFS II Holding GmbH & Co. KG

    Shares: 8,753,595.00 · Class: 3.9%

  • Zweite DH Verwaltungs GmbH

    Shares: 3,404,672.00 · Class: 1.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-054753
Form type
SCHEDULE 13D/A
Filer
CureVac N.V.
CIK
CIK 1809122
Filed
Jun 16, 2025
Reporting period
Jun 12, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub